However, according to our data those patients with BMI over 35 kg/m2 treated with different insulin regimes regardless of baseline HbA1c level and duration of diabetes could benefit from this specific combination with regard to not only weight and hypoglycemia reduction, but also HbA1c improvement. This evidence concerns the gene INS and diabetes mellitus.